Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06983366 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

StatusRecruiting
PhaseNot specified
Started2025-05-30
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 4 months later Jul 1, 2026 → Nov 1, 2026
See other at-risk trials from Assiut University

Amendment history

2026-09-23
Primary completion pushed: 2026-07-01 → 2026-11-01
Completion pushed: 2026-08-01 → 2026-12-01
2026-04-26
Study Status, Arms and Interventions v3
Primary completion date2026-01-01→2026-07-01
Completion date2026-03-01→2026-08-01
2025-07-16
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Study sites1 entry, revised
AssuitAssiut University Hospitals - Faculty of Medicine - Assuit University
2025-05-20
Study Status, Study Description, Arms and Interventions, Eligibility, Contacts/Locations v1
Eligibility criteria+10 characters
Inclusion Criteria: Age ≥18 years and older. Diagnosed with one of the specified pulmonary diseases, or [...]
Study description+24 characters
[...] ained from all participants. The study groups will include: 1- Pneumothorax 2. Interstitial lung disease (ILD/IPF) 3. COPD/emphysema 4. Bronchiectasis 5. Community-acquired pneumonia 6. Pulmonary edema 7- Pleural effusion 8. Healthy controls Data Collection Methods: Standardized data [...]
2025-05-13
Original filing
Assiut University
1,604 trials monitored
See 18 trials at risk
COPD
1,057 trials monitored
See 28 trials at risk
This upcoming case-control study aims to confirm the Lung Sliding Index (LSI), a new ultrasound score that measures how well the pleura moves, in various lung diseases. The study will check how well the LSI can tell apart different lung diseases (like pneumothorax, interstitial lung disease, COPD, pneumonia, and pulmonary edema), how it relates to signs of disease severity, and how consistent the results are between different operators who have received the same training. Secondary objectives include assessing patient and operator satisfaction and feasibility using validated Likert scales.
Trial Details
NCT Number NCT06983366
Lead Sponsor Assiut University
Collaborators: Aliae AR Mohamed Hussein [ahussein
Conditions COPD, ILD, Bronchiectasis, Pneumothorax, Pneumonia, Pleural Effusion Disorder, Pulmonary Oedema
Enrollment 700 participants
Start Date 2025-05-30
Primary Completion 2026-11-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-22